Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Author affiliations: Hôpital Européen, Marseille, France (S. Rebaudet); Aix Marseille Univ, Institut National de la Santé et de la Recherche Médicale, Institut de Recherche pour le Développement, Sciences Économiques et Sociales de la Santé et Traitement de L’information Médicale, ISSPAM, Marseille (S. Rebaudet); Institut Pierre-Louis d’Epidémiologie et de Santé Publique, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Paris, France (S. Rebaudet, R. Piarroux); Direction d’Epidémiologie des Laboratoires et de la Recherche, Ministère de la Santé Publique et de la Population, Delmas, Haiti (P. Dély); Faculté de Médecine et de Pharmacie, Université d’Etat d’Haïti, Port-au-Prince, Haiti (P. Dély); Laboratoire National de Santé Publique, Ministère de la Santé Publique et de la Population, Delmas (J. Boncy); Laboratoire Santé-Environnement, Université Quisqueya, Port-au-Prince (J.H. Henrys); AP-HP, Hôpital Pitié-Salpêtrière, Paris (R. Piarroux)
After cholera was reintroduced into Haiti in 2010 (1), the country experienced an epidemic of unparalleled magnitude: the 9,789 recorded casualties represent the largest number for a single epidemic in the past 20 years (https://apps.who.int/gho/data/node.main.174). Unfortunately, vulnerabilities of people in Haiti to fecal–oral diseases such as cholera have barely been reduced over the past decade. The National Plan for the Elimination of Cholera 2013–2022 aimed to improve access to drinking water to >85% of the population, access to sanitation to >90% of the population, and access to healthcare to >80% of the population (2). However, these indicators improved very slowly or even deteriorated during 2012–2017 (3). The country still faces a deep economic and social crisis and has also endured several natural disasters, such as Hurricane Matthew in October 2016. In addition, the Multi-Partner Trust Fund set in December 2016 by the United Nations to support the response to cholera in Haiti gathered only US $20.8 million during 2016–2020 (https://mptf.undp.org/factsheet/fund/CLH00).
To alleviate these persisting vulnerabilities and eliminate cholera transmission, experts and public health institutions have appealed to expand mass use of oral cholera vaccines (OCV) (4,5). Meanwhile, a nationwide coordinated rapid response strategy structured around case-area targeted interventions was gradually implemented beginning in July 2013 by the Ministry of Public Health and Population of Haiti (MOH), UNICEF, and other partners (6). Analogous to forest fire management, the strategy aimed to rapidly detect local outbreaks and send rapid response teams, mostly composed of nongovernmental organization and MOH staff, to the households and neighbors of infected persons (Appendix). This study aims to describe and decipher the progress of cholera control in Haiti.
We analyzed cholera surveillance data routinely collected since 2010 by the MOH with support of the Pan American Health Organization and the Centers for Disease Control and Prevention, including results of stool cultures searching for Vibrio cholerae O1 (Appendix). The study was approved by the Bioethics National Committee of the MOH (authorization no. 1819-41). Suspected cholera cases stagnated during 2013–2016; the median was 38,733 annual cases (incidence rate 6.9/100,000 person-weeks). Incidence then dramatically decreased to 13,681 cases (incidence rate 2.2/100,000 person-weeks) in 2017, to 3,777 cases (incidence rate 0.6/100,000 person-weeks) in 2018, and to 720 cases in 2019 (incidence rate 0.1/100,000 person-weeks). The last cluster of suspected cholera cases and the last cholera-associated death were observed in the commune of L’Estère, Artibonite department, in February 2019. As of July 1, 2021, a total of 92 (67%) of the 140 communes have not notified a case for >3 years (Figure 1, panel A). Of note, the last stool culture positive for V. cholerae O1 was also sampled in L’Estère on February 4, 2019; none of the 5,223 consecutive stool specimens sampled from diarrheic patients across the country, including 2,255 specimens sampled in 2021, have tested positive since 2019 (Figure 1, panel B). Reports of cholera have thus halted for >3 years in 112 (80%) of communes in Haiti (Figure 1, panel A).
To analyze factors associated with this apparent discontinuation of cholera transmission in February 2019, we compiled data from mass OCV campaigns implemented across Haiti (Appendix). During 2012–2018, the MOH recorded 33 campaigns targeting 31 communes and 16 prisons (Table 1; Figure 2, panel A). A total of 1,576,209 persons received >1 dose. The 2-dose regimen was completed for 74% of these persons, with marked heterogeneity (Figure 2, panel A). Overall, <10% of the population in Haiti has been fully vaccinated (Table 1). Considering the duration of protection of 1-dose and 2-dose regimens of OCVs (7), only 2.4% of persons in Haiti were likely still protected in 2019 (Table 1).
We compiled a total of 48,710 case-area targeted interventions recorded by UNICEF during July 2013–December 2019 that were implemented across 139 administrative communes (Table 2; Figure 2, panel B). Of those interventions, ≈71% involved a complete package: house decontamination by chlorine spraying, health education about cholera, distribution of soap and chlorine tablets for household water treatment, and distribution of antibiotic prophylaxis to close contacts of cholera cases. Progress from 2013 to 2019 was strong (Table 2), and spatial heterogeneity was marked (Figure 2, panel B). The overall number of case-area targeted interventions per suspected cholera case was 0.3; this ratio improved markedly during 2013–2019 (Table 2).
As confirmed by an extensive laboratory-based surveillance effort, despite sociopolitical turmoil, the cholera epidemic in Haiti seems to be ending. However, a high-coverage national 2-dose cholera vaccination campaign could not be implemented, because neither the required stockpile nor the funds, estimated at US $66 million (5), have been available. Although OCV campaigns proved effective in some targeted areas (8), these limited and incomplete campaigns were insufficient to compensate for the global waning of the herd immunity built up during the initial incidence peaks of 2010–2012. In the absence of major progress in water, sanitation, and hygiene indicators, most of the fight against cholera transmission has thus been conducted through the nationwide rapid response strategy, which was gradually implemented beginning in mid-2013 (6) and was shown to effectively shorten and mitigate cholera outbreaks in Haiti (9).
According to observational and experimental results from Bangladesh, vibriophages might play a role in the natural control of cholera epidemics (10). Although a single phage isolation was reported in Haiti in 2013 (11), vibriophages might have influenced the seasonal dynamic of cholera. Whether they have also contributed to the epidemic collapse requires further investigation.
Because reports of long-term carriers of cholera are anecdotal and they have not been shown to trigger outbreaks (12), the critical issue now is whether the epidemic strain of V. cholerae O1 has settled in Haiti and could lead to the reemergence of cholera in the near future (13). This scenario explicitly informed the Elimination Plan, which required substantial progress in human development to limit the annual incidence rate of cholera to 0.01% of the population (2). According to the published literature (13,14), no epidemic strain seems to have been isolated in surface waters in Haiti since November 2015. Until then, environmental isolates had remained sporadic and usually concomitant to local cholera cases; therefore, differentiating a true environmental reservoir from a recent fecal contamination remains controversial (13,14). Cholera recurrence after lull periods might simply come from a low-grade and underreported persistent interhuman transmission (14) rather than from aquatic reservoirs (13).
Because cholera has not been reported in the neighboring Dominican Republic since 2018 (http://digepisalud.gob.do/documentos), the island of Hispaniola might now be located thousands of kilometers away from current transmission foci. In the past, numerous countries in Africa have experienced severe epidemics and prolonged remissions, despite low human development indices, and have remained free from cholera for years (e.g., 8 years for Guinea and 19 years for Madagascar). Similarly, the absence of cholera outbreaks in South America since the early 2000s, despite a large epidemic wave in the 1990s, is reason for optimism.
Until the certification of cholera elimination by the World Health Organization, systematic bacteriologic testing of every case of severe acute watery diarrhea, combined with environmental monitoring, should be maintained in Haiti. However, achieving 2.5 years with no deaths from cholera or confirmed cholera cases in a country where the disease was considered impregnable is already a victory. This achievement should be considered a springboard to further understand cholera epidemics and improve control strategies worldwide. This success should foster investments in water, sanitation, and hygiene infrastructure, which will protect Haiti against possible future cholera epidemics and against other remaining waterborne diseases.
Dr. Rebaudet is an infectious diseases physician and epidemiologist working in Marseille, France. His primary research interests are the epidemiology and control of cholera and antimicrobial stewardship.
We are grateful to the staff of the MOH, UNICEF, Pan American Health Organization, Centers for Disease Control and Prevention, Direction Nationale de l’Eau Potable et de l’Assainissement, nongovernmental organizations, and others, who took part in patients’ care, field responses, stool specimens sampling and analysis, and compiling epidemiological and intervention data.
The study was partly funded by UNICEF, Assistance Publique Hôpitaux de Marseille, Assistance Publique Hôpitaux de Paris, and Sorbonne University.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.